BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26827110)

  • 1. Subjective perceived outcome of subthalamic deep brain stimulation in Parkinson's disease one year after surgery.
    Maier F; Lewis CJ; Horstkoetter N; Eggers C; Dembek TA; Visser-Vandewalle V; Kuhn J; Zurowski M; Moro E; Woopen C; Timmermann L
    Parkinsonism Relat Disord; 2016 Mar; 24():41-7. PubMed ID: 26827110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach.
    Maier F; Lewis CJ; Horstkoetter N; Eggers C; Kalbe E; Maarouf M; Kuhn J; Zurowski M; Moro E; Woopen C; Timmermann L
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1273-81. PubMed ID: 23715910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease patients with subthalamic stimulation and carers judge quality of life differently.
    Lewis CJ; Maier F; Eggers C; Pelzer EA; Maarouf M; Moro E; Zurowski M; Kuhn J; Woopen C; Timmermann L
    Parkinsonism Relat Disord; 2014 May; 20(5):514-9. PubMed ID: 24637125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease.
    Martinez-Fernandez R; Pelissier P; Quesada JL; Klinger H; Lhommée E; Schmitt E; Fraix V; Chabardes S; Mertens P; Castrioto A; Kistner A; Broussolle E; Pollak P; Thobois S; Krack P
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):311-8. PubMed ID: 25934016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease.
    Higuchi MA; Tsuboi Y; Inoue T; Fukuyama K; Abe H; Baba Y; Yamada T
    Neuromodulation; 2015 Feb; 18(2):113-7. PubMed ID: 24799286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease.
    Bargiotas P; Eugster L; Oberholzer M; Debove I; Lachenmayer ML; Mathis J; Pollo C; Schüpbach WMM; Bassetti CL
    PLoS One; 2017; 12(12):e0190027. PubMed ID: 29253029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.
    Drapier S; Raoul S; Drapier D; Leray E; Lallement F; Rivier I; Sauleau P; Lajat Y; Edan G; Vérin M
    J Neurol; 2005 May; 252(5):583-8. PubMed ID: 15778909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy.
    Rothlind JC; York MK; Carlson K; Luo P; Marks WJ; Weaver FM; Stern M; Follett K; Reda D;
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):622-9. PubMed ID: 25185211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between bilateral subthalamic nucleus deep brain stimulation (STN-DBS) and anxiety in Parkinson's disease patients: a controlled study.
    Chang C; Li N; Wu Y; Geng N; Ge S; Wang J; Wang X; Wang X
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):316-25. PubMed ID: 23037645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of subthalamic deep brain stimulation on caregivers of Parkinson's disease patients: an exploratory study.
    Lewis CJ; Maier F; Horstkötter N; Eggers C; Visser-Vandewalle V; Moro E; Zurowski M; Kuhn J; Woopen C; Timmermann L
    J Neurol; 2015 Feb; 262(2):337-45. PubMed ID: 25381461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Boel JA; Odekerken VJ; Schmand BA; Geurtsen GJ; Cath DC; Figee M; van den Munckhof P; de Haan RJ; Schuurman PR; de Bie RM;
    Parkinsonism Relat Disord; 2016 Dec; 33():90-95. PubMed ID: 27688200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and coping as predictors of change after deep brain stimulation in Parkinson's disease.
    Soulas T; Sultan S; Gurruchaga JM; Palfi S; Fénelon G
    World Neurosurg; 2011; 75(3-4):525-32. PubMed ID: 21600507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.
    Volkmann J; Albanese A; Kulisevsky J; Tornqvist AL; Houeto JL; Pidoux B; Bonnet AM; Mendes A; Benabid AL; Fraix V; Van Blercom N; Xie J; Obeso J; Rodriguez-Oroz MC; Guridi J; Schnitzler A; Timmermann L; Gironell AA; Molet J; Pascual-Sedano B; Rehncrona S; Moro E; Lang AC; Lozano AM; Bentivoglio AR; Scerrati M; Contarino MF; Romito L; Janssens M; Agid Y
    Mov Disord; 2009 Jun; 24(8):1154-61. PubMed ID: 19412954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apathy in patients with Parkinson's disease following deep brain stimulation of the subthalamic nucleus.
    Hindle Fisher I; Pall HS; Mitchell RD; Kausar J; Cavanna AE
    CNS Spectr; 2016 Jun; 21(3):258-64. PubMed ID: 27151388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease.
    Dafsari HS; Weiß L; Silverdale M; Rizos A; Reddy P; Ashkan K; Evans J; Reker P; Petry-Schmelzer JN; Samuel M; Visser-Vandewalle V; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Brain Stimul; 2018; 11(4):867-874. PubMed ID: 29655587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
    Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
    Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological and psychiatric assessments following bilateral deep brain stimulation of the subthalamic nucleus in Japanese patients with Parkinson's disease.
    Aono M; Iga J; Ueno S; Agawa M; Tsuda T; Ohmori T
    J Clin Neurosci; 2014 Sep; 21(9):1595-8. PubMed ID: 24794694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.